The present invention relates to the proliferation of primary cholangiocyte cells in the form of cholangiocyte organoids (CO) using culture conditions in which classical Wnt signaling is inhibited and non-classical Wnt/PCP signaling is enhanced. Methods of expanding primary cholangiocytes, populations of expanded cholangiocytes and medical uses of expanded cholangiocytes are provided. [Selection diagram] None
展开▼